Nasdaq: AVIR
Atea Pharmaceuticals insiders
The officers, directors and 10% owners of Atea Pharmaceuticals, Inc. who hold the most stock, valued at the live AVIR price.
$3.93
AVIR today −$60K (−1.50%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 1
- Their AVIR stock
- $26.1M
- Market value
- $316M
- Held by ranked insiders
- 8.26%
Insiders by value of AVIR holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Jean-Pierre Sommadossi | President, CEO, and Chairman | 6,633,855 | $26.1M | 8.26% | 4232nd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Atea Pharmaceuticals; see each profile for the filing.